Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-TECHNE Corp Director's Dealing 2008

Jul 28, 2008

30718_dirs_2008-07-28_858644b6-98a4-45cb-b1c2-7864c0a7cf54.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TECHNE CORP /MN/ (TECH)
CIK: 0000842023
Period of Report: 2008-07-25

Reporting Person: VERONNEAU MARCEL (VP-Hematology Operations)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-07-25 Employee stock option $79.41 A 385 Acquired 2015-07-24 Common Stock (385) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 30862 Direct
Common Stock 6476 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Employee stock option $56.83 2014-07-26 Common Stock (510) 510 Direct
Employee stock option $49.43 2013-07-27 Common Stock (567) 567 Direct
Employee stock option $51.6 2012-08-17 Common Stock (475) 475 Direct
Employee stock option $37.011 2010-11-30 Common Stock (15000) 15000 Direct
Employee stock option $40.47 2011-07-08 Common Stock (505) 505 Direct
Employee stock option $33.85 2010-08-13 Common Stock (670) 670 Direct
Employee stock option $28.22 2009-06-30 Common Stock (785) 785 Direct

Footnotes

F1: Exercisable 5000 each on 12/1/03, 12/1/04 and 12/1/05